Marko Radulovic | Precision Medicine | Research Excellence Award

Published on by Scientist Day

Research Excellence Award – Marko Radulovic

Marko Radulovic

Institute for Oncology and Radiology, Serbia

Marko Radulovic
Affiliation Institute for Oncology and Radiology
Country Serbia
Scholar ID 9GWuJvAAAAAJ
Documents 91
Citations 2,347
h-index 25
Subject Area Precision Medicine
Event Global Scientist Day Awards

Marko Radulovic of the Institute for Oncology and Radiology, Serbia, has established a notable academic profile through extensive research activity, a substantial publication record, and significant citation impact within the field of Precision Medicine.[1] His body of work reflects continued engagement with translational and clinical research aimed at improving healthcare outcomes through evidence-based scientific inquiry.[2]

Abstract

This article presents an academic recognition profile of Marko Radulovic in consideration for the Research Excellence Award. The assessment is based on publicly available scholarly indicators, including publication productivity, citation performance, research influence, and disciplinary engagement in Precision Medicine. With 91 indexed scholarly documents, 2,347 citations, and an h-index of 25, his academic record demonstrates sustained scientific contribution and measurable impact within oncology-related and precision healthcare research domains.[1]

Keywords

Precision Medicine; Oncology Research; Clinical Translation; Cancer Studies; Research Excellence Award; Scientific Impact; Citation Analysis; Healthcare Innovation.

Introduction

Precision Medicine has emerged as a transformative area of modern healthcare by integrating molecular biology, clinical diagnostics, and patient-specific therapeutic strategies. Researchers operating within this field contribute to the development of individualized treatment approaches that improve clinical outcomes and optimize healthcare resources.[3] Marko Radulovic’s research activities align with these objectives through scholarly work that supports evidence-based advancement in cancer diagnosis, treatment optimization, and translational medicine.[2]

Research Profile

Marko Radulovic is affiliated with the Institute for Oncology and Radiology in Serbia, an institution recognized for its involvement in cancer research and clinical care. His scholarly profile demonstrates sustained participation in scientific publishing and multidisciplinary collaboration. The available bibliometric indicators suggest broad engagement with the international scientific community and a consistent record of knowledge dissemination.[1]

  • Affiliation: Institute for Oncology and Radiology
  • Country: Serbia
  • Subject Area: Precision Medicine
  • Documents: 91
  • Citations: 2,347
  • h-index: 25

Research Contributions

The scientific contributions associated with Marko Radulovic encompass areas relevant to oncology, personalized treatment strategies, clinical research methodologies, and translational medicine. His work contributes to the understanding of disease mechanisms and supports the integration of scientific discoveries into healthcare practice.[2]

  • Advancement of precision-based clinical approaches.
  • Contribution to oncology-related scientific literature.
  • Support for evidence-driven patient management strategies.
  • Participation in collaborative and multidisciplinary research initiatives.
  • Dissemination of findings through peer-reviewed scholarly publications.

Publications

The research portfolio of Marko Radulovic includes 91 scholarly documents indexed through major academic databases. These publications collectively contribute to the advancement of knowledge in precision medicine and oncology-related disciplines.[1]

  1. Peer-reviewed research articles.
  2. Clinical and translational research studies.
  3. Collaborative multidisciplinary publications.
  4. Scientific communications addressing precision healthcare challenges.

Research Impact

Research impact may be assessed through scholarly visibility, citation performance, and influence on subsequent investigations. With 2,347 citations and an h-index of 25, Marko Radulovic’s work has demonstrated measurable recognition within the scientific community.[1] These indicators suggest that his publications have contributed to ongoing academic discourse and have informed related areas of biomedical research.[2]

Award Suitability

Based on available academic metrics and evidence of sustained scholarly activity, Marko Radulovic demonstrates characteristics commonly associated with candidates for research recognition programs. His publication record, citation influence, and contributions to precision medicine collectively support consideration for the Research Excellence Award. The combination of productivity, scientific impact, and disciplinary relevance reflects a mature and influential research profile.[1]

Conclusion

Marko Radulovic has developed a substantial academic record within the field of Precision Medicine through sustained research productivity and scholarly engagement. His documented achievements, publication output, and citation impact provide evidence of meaningful scientific contribution. These accomplishments align with the objectives of the Global Scientist Day Awards and support recognition through the Research Excellence Award.[1]

References

  1. Google Scholar. (n.d.). Marko Radulovic Citation Profile and Scholarly Metrics. Google Scholar. https://scholar.google.com/citations?user=9GWuJvAAAAAJ&hl=en&oi=ao
  2. Discriminative Pattern Mining for Breast Cancer Histopathology Image Classification via Fully Convolutional Autoencoder.
    https://ieeexplore.ieee.org/abstract/document/8664469
  3. Pharmacology and Biology of Corticotropin-Releasing Factor (CRF) Receptors.
    https://www.tandfonline.com/doi/abs/10.3109/10606820213678
  4. Corticotropin-Releasing Factor Receptor 1 in Mouse Spleen: Expression After Immune Stimulation and Identification of Receptor-Bearing Cells. https://academic.oup.com/jimmunol/article-abstract/162/5/3013/8041238

Simon Podnar | Medical Discoveries | Research Excellence Award

Published on by Scientist Day

Prof. Simon Podnar | Medical Discoveries | Research Excellence Award

University Medical Centre Ljubljana | Slovenia

Prof. Simon Podnar, MD, DSc, is a distinguished neurologist and clinical neurophysiologist at the University of Ljubljana and the University Medical Center Ljubljana. He specializes in electromyography, neuromuscular imaging, and advanced neurophysiological diagnostics, with international training across Europe and the United States. He introduced neuromuscular ultrasonography to Slovenia and has held major leadership roles in national and international neurological societies. He leads Slovenia’s only state-funded clinical neurological research program, serves on leading journal editorial boards, and has authored over 400 scientific works, including influential discoveries in neuromuscular and peripheral nerve disorders.

Citation Metrics (Scopus)

4000
3000
2000
1000
0

Citations
2,724

Documents
132

h-index
30

Citations

Documents

h-index


View Scopus Profile
 View Orcid Profile
 View Google Scholar Profile

Featured Publications

Ahmed Hamdan | Pharmaceutical and Clinical Sciences | Research Excellence Award

Published on by Scientist Day

Dr. Ahmed Hamdan | Pharmaceutical and Clinical Sciences | Research Excellence Award

University of Tabuk | Saudi Arabia

Dr. Ahmed Mohsen Elsaid Hamdan is an Assistant Professor in the Department of Pharmacology and Toxicology at the University of Tabuk, with more than 14 years of academic and research experience in pharmaceutical sciences. His research is centered on chronopharmacology, chronotherapeutics, and smart drug delivery systems, with a strong translational focus on neurological and neurodevelopmental disorders. His work aims to elucidate how biological rhythms and circadian regulation influence drug efficacy, toxicity, and disease progression. A major theme of Dr. Hamdan’s research is the development of evidence-based non-pharmacological and nutritional therapeutic strategies for neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases, as well as neurodevelopmental disorders including autism spectrum disorder and ADHD. He extensively investigates phytochemicals, probiotics (particularly Lactobacillus species), and nutraceuticals, emphasizing the gut–microbiome–brain axis as a key mechanistic pathway. His studies integrate pharmacological, behavioral, biochemical, and molecular approaches to identify novel therapeutic targets and mechanisms. In parallel, Dr. Hamdan has contributed significantly to advanced nano- and smart drug delivery systems for cancer therapy, dermatological disorders, infectious diseases, and chronic inflammatory conditions, enhancing drug bioavailability and therapeutic outcomes. His research portfolio also includes hepatoprotective and cardioprotective strategies and chronopharmacological exploration of natural products. Dr. Hamdan has published 105 peer-reviewed articles, with the majority appearing in high-impact Q1–Q2 journals, and holds an h-index of 26. He has secured 13 competitive research grants, is involved in an ongoing patent, and maintains active collaborations with national and international institutions, reflecting his strong commitment to innovative and multidisciplinary biomedical research.

Citation Metrics (Scopus)

1300
900
500
100
    0

Citations
1,047

Documents
69

h-index
19

Citations

Documents

h-index


View Scopus Profile View ORCID Profile View Google Scholar Profile

Featured Publications

Sylvia Mangani | Medical Discoveries | Best Researcher Award

Published on by Scientist Day

Ms. Sylvia Mangani | Medical Discoveries | Best Researcher Award

Ms. Sylvia Mangani | University of Patras | Greece

Sylvia Mangani is a biochemist–biotechnologist and PhD candidate in Biochemistry at the University of Patras, whose research centers on cancer biology, particularly the influence of the extracellular matrix on tumor growth and regulation through 3D cell culture systems. Her academic journey combines strong foundations in biochemistry and biotechnology (BSc, MSc) with advanced experimental and analytical expertise. Her work integrates a broad range of molecular and cellular biology techniques, including quantitative PCR, Western blotting, immunofluorescence, functional assays, and RNA sequencing, complemented by bioinformatics analysis for gene expression and signaling pathway interpretation. Her research has significantly contributed to understanding how 3D cellular microenvironments influence cancer progression, focusing on breast cancer models. She has authored 12 peer-reviewed publications in recognized international journals, with her work cited over 55 times according to Google Scholar, reflecting growing recognition within the scientific community. Her contributions have also supported award-winning synthetic biology initiatives under the iGEM program and have been presented at national and international scientific conferences. She has established productive collaborations with prominent research institutions in Greece and abroad. Notably, she completed a funded Erasmus+ research placement at the University Hospital of Münster, Germany, under the supervision of Prof. Martin Götte, where she engaged in experimental oncology projects exploring cancer cell behavior and matrix interactions. She has also collaborated with the National and Kapodistrian University of Athens on biochemical and molecular analyses within the Laboratory of Biochemistry, Biotechnology, and Molecular Analysis. A member of the Hellenic Society of Biochemistry and Molecular Biology (HSBMB), she actively contributes to the advancement of biochemical and cancer research in Greece and Europe. Her ongoing studies aim to deepen the understanding of tumor–matrix dynamics in breast cancer, offering new insights for therapeutic innovation and cancer model development, positioning her among emerging researchers in molecular oncology.

Profiles: Orcid | Google Scholar | LinkedIn | Research Gate

Featured Publications 

Mangani, S., Piperigkou, Z., Mangani, S., Koletsis, N. E., Koutsakis, C., Mastronikolis, N. S., Franchi, M., & Karamanos, N. K. (2025, August). Principal mechanisms of extracellular matrix‐mediated cell–cell communication in physiological and tumor microenvironments. The FEBS Journal. https://doi.org/10.1111/febs.70207

Mangani, S., Vetoulas, M., Mineschou, K., Spanopoulos, K., Vivanco, M. d. M., Piperigkou, Z., & Karamanos, N. K. (2025, July 15). Design and applications of extracellular matrix scaffolds in tissue engineering and regeneration. Cells, 14(14), 1076. https://doi.org/10.3390/cells14141076

Franchi, M., Masola, V., Onisto, M., Franchi, L., Mangani, S., Zolota, V., Piperigkou, Z., & Karamanos, N. K. (2025, July 7). Ultrastructural changes of the peri-tumoral collagen fibers and fibrils array in different stages of mammary cancer progression. Cells, 14(13), 1037. https://doi.org/10.3390/cells14131037

Karamanos, N. K., Piperigkou, Z., Gourdoupi, C., Mangani, S., & Vivanco, M. d. M. (2025, June 1). Extracellular matrix matters: Matrix-based bioscaffolds in advancing translational cancer research and targeted therapy. American Journal of Physiology-Cell Physiology, 328(6), C1235–C1251. https://doi.org/10.1152/ajpcell.00050.2025

Ciampelli, C., Mangani, S., Nieddu, G., Formato, M., Ioannou, P., Kremmydas, S., Karamanos, N., & Lepedda, A. J. (2025, March). Effects of acidic polysaccharide-enriched extracts from Holothuria tubulosa on two- and three-dimensional invasive breast cancer cell models. Biology, 14(4), 334. https://doi.org/10.3390/biology14040334

Mangani, S., Kremmydas, S., & Karamanos, N. K. (2025, March). Mimicking the complexity of solid tumors: How spheroids could advance cancer preclinical transformative approaches. Cancers, 17(7), 1161. https://doi.org/10.3390/cancers17071161

Iffat Prianka | Public Health | Best Researcher Award

Published on by Scientist Day

Assist. Prof. Dr. Iffat Prianka | Public Health | Best Researcher Award

Assist. Prof. Dr. Iffat Prianka | Ibrahim Medical College | Bangladesh

Dr. Iffat Tania Prianka is an accomplished public health researcher and academic with extensive experience in community medicine, preventive and social medicine, and epidemiology. She holds an M. Phil. in Preventive and Social Medicine and an MPH in Epidemiology, and is currently pursuing a PhD. Her academic contributions include research on autism awareness among medical students, internet addiction, physical exercise practices among diabetic patients, and mental stress in infertile women. Dr. Prianka has served in diverse roles including Lecturer and Assistant Professor at Ibrahim Medical College, Senior House Physician at United Hospital Dhaka, and Lead Medical Officer and Public Health Expert at Fera Foundation, USA. She has significant experience in research methodology, data analysis, manuscript preparation, and public health program implementation. Her professional development includes international training in medical education, research methodology, data interpretation, and faculty development programs. She has presented at international conferences, received awards for academic excellence, and published multiple peer-reviewed research articles in reputable journals. Dr. Prianka is proficient in statistical software (SPSS, STATA) and skilled in scientific communication, teaching, and community health research.

Profile: Orcid

Featured Publications

Prianka, I. T., Haque, W., Jahan, N., Saha, M., Prity, T. T., & Gupta, P. K. S. (2022). Knowledge and attitude on early sign of autism among 1st year to 3rd year medical students in a selected medical college in Bangladesh. International Journal of Medical Research and Pharmaceuticals, 9(9).

Jahan, N., Idris, M. R., Prianka, I. T., & Gupta, P. K. S. (2022). Internet addiction and its determinants among medical students in Dhaka City during COVID-19 pandemic. International Journal of Medical Research and Pharmaceuticals, 9(12).